Evidence map›Paper›PMID 34639307›Full record

ArticleInternational journal of environmental research and public health2021

The Epidemiologic Characteristics of Malignant Mesothelioma Cases in Korea: Findings of the Asbestos Injury Relief System from 2011-2015.

Soon-Chan Kwon, Sung-Soo Lee, Min-Sung Kang, Da-An Huh, Yong-Jin Lee

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Soon-Chan KwonDepartment of Occupational and Environmental Medicine, Soonchunhyang University Cheonan Hospital, Cheonan-si 31151, Korea.ORCID 0000-0002-5782-6087
Sung-Soo LeeDepartment of Preventive Medicine, Soonchunhyang University College of Medicine, Cheonan-si 31151, Korea.
Min-Sung KangAsbestos Environmental Health Center, Soonchunhyang University Cheonan Hospital, Cheonan-si 31151, Korea.
Da-An HuhInstitute of Health Sciences, Korea University, Seongbuk-gu, Seoul 02841, Korea.ORCID 0000-0001-7633-0805
Yong-Jin LeeDepartment of Occupational and Environmental Medicine, Soonchunhyang University Cheonan Hospital, Cheonan-si 31151, Korea.
Soonchunhyang University · KRKorea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: The purpose of this study was to investigate the epidemiological characteristics of malignant mesothelioma in Korea by investigating cases compensated under the asbestos injury relief system. (2) Methods: A total of 407 compensated cases between 2011 and 2015 were reviewed using medical records and resident registrations in order to investigate the dates of diagnosis and death. Asbestos exposure and patients' general characteristics were investigated through face-to-face interviews. The standardized incidence ratio was calculated as the number of observations from 2005 to 2014 per exposure region in Korea, using the mid-annual population of each region in 2009 as the standard population. (3) Results: Among the 407 cases, 65.1% were male. The pleura and peritoneum were affected in 76.9% and 23.1% of cases, respectively. For peritoneal mesothelioma, the median survival duration was longer (

Indexed as

AsbestosMesotheliomaMesothelioma, MalignantOccupational ExposureFemaleHumansIncidenceItalyMaleRepublic of KoreaAsbestosasbestosincidencelatent periodmalignant mesotheliomasurvival

Identifiers

PMID34639307
PMCPMC8508037
OpenAlexW3200413305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.